Merck MRK

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Germany's Merck expects drug division to drive growth-Euro am Sonntag

      Headlines

      Sat, 23 May 2015

      FRANKFURT, May 23 (Reuters) - Germany's Merck KGaA expects sales to grow by around 5 percent in its core operations over coming years, helped by its pipeline of prospective new drugs, its chief executive was quoted saying by weekly Euro am Sonntag.

    2. Merck follows Bristol with EU green light for immune cancer drug

      Headlines

      Fri, 22 May 2015

      May 22 (Reuters) - European regulators have recommended approval of Merck & Co Inc's immune system-boosting cancer drug Keytruda, following a similar green light last month for Bristol-Myers Squibb Co's rival product Opdivo.

    3. 4 Companies Leading the Next Wave of Cancer-Drug Innovation

      Video Reports

      Thu, 21 May 2015

      Along with Bristol, there's Merck ( MRK ), [TICKER:RHHBY] Roche (RHHBY ..... AstraZeneca are very well positioned. Merck is well in the lead with immuno-oncology ..... firms and that Bristol-Myers and Merck look like some of the best investment

      Merck MRK found at 0:56

      front of the leadership pack is [TICKER:BMY] Bristol-Myers (BMY). Along with Bristol, there's Merck ( MRK ), [TICKER:RHHBY] Roche (RHHBY), and [TICKER:AZN] AstraZeneca (AZN) as well. So, those are the four names that we see as really leading this next wave
    4. Merck KGaA Mostly Meets Expectations During a Challenging Quarter

      Commentary

      Tue, 19 May 2015

      Merck KGaA’s first-quarter results mostly matched ..... enhanced scale this acquisition provides in Merck ’s life sciences operations, we’re ..... higher research and development spending as Merck advances its PD-L1 drug into Phase III trials

    5. UPDATE 2- Merck KGaA sees AZ deal and forex countering weak drug sales

      Headlines

      Tue, 19 May 2015

      FRANKFURT, May 19 (Reuters) - The recent takeover of high-tech chemicals maker AZ Electronic Materials and a strong U.S. dollar will help Merck KGaA to counter a drop in revenue from its best-selling drug this year, it said on Tuesday.

    6. RPT- Merck KGaA says to overcome EU concerns on Sigma-Aldrich deal

      Headlines

      Tue, 19 May 2015

      FRANKFURT, May 19 (Reuters) - Merck KGaA said European Union antitrust regulators had concerns "of a limited nature" about its planned takeover of laboratory supplies maker Sigma-Aldrich but it expects to wrap up the deal around mid-year.

    7. Merck KGaA says to overcome EU concerns on Sigma-Aldrich deal

      Headlines

      Tue, 19 May 2015

      FRANKFURT, May 19 (Reuters) - Merck KGaA said European Union antitrust regulators had concerns "of a limited nature" about its planned takeover of laboratory supplies maker Sigma-Aldrich but it expects to wrap up the deal around mid-year.

    8. BRIEF- Merck KGaA sees positive forex effects declining in H2

      Headlines

      Tue, 19 May 2015

      * says positive currency effects will decline significantly in Q3 and Q4 Further company coverage:

    9. Merck sees up to 4.8 pct gain in 2015 adj EBITDA on weak euro

      Headlines

      Tue, 19 May 2015

      FRANKFURT, May 19 (Reuters) - Merck KGaA said 2015 adjusted core earnings would rise to 3.45-3.55 billion euros ($3.9-4.0 billion) in 2015, helped

    10. UPDATE 1-Indian court bars Glenmark from selling Merck drug copies

      Headlines

      Fri, 15 May 2015

      MUMBAI, May 15 (Reuters) - India's Supreme Court has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck 's diabetes drugs Januvia and Janumet, according to a court...

    « Prev12345Next »
    Content Partners